Search

West Pharmaceutical Services Inc

Ouvert

SecteurSoins de santé

370.22 -0.82

Résumé

Variation du prix de l'action

24h

Actuel

Min

368.69

Max

382.23

Chiffres clés

By Trading Economics

Revenu

15M

154M

Ventes

27M

872M

P/E

Moyenne du Secteur

46.204

55.725

BPA

2.37

Rendement du dividende

0.24

Marge bénéficiaire

17.654

Employés

10,800

EBITDA

-39M

179M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+10.31% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

0.24%

2.25%

Prochains Résultats

22 oct. 2026

Date du Prochain Dividende

18 nov. 2026

Date du Prochain Détachement de Dividende

11 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

570M

25B

Ouverture précédente

371.04

Clôture précédente

370.22

Sentiment de l'Actualité

By Acuity

100%

0%

307 / 339 Classement par Healthcare

West Pharmaceutical Services Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 sept. 2026, 22:40 UTC

West Pharmaceutical Services Inc declined in after-hours trading, reversing an initial gain, despite remaining above its 20-day moving average.

23 sept. 2026, 23:51 UTC

West Pharmaceutical Services Inc is seeing a modest decline in after-market trading, positioned at the lower end of today's range but above its 20-day moving average.

22 sept. 2026, 20:02 UTC

News

Morgan Stanley upgraded West Pharmaceutical Services Inc to Overweight and raised its price target to $400, contributing to a significant rise in the stock.

18 sept. 2026, 20:03 UTC

West Pharmaceutical Services Inc shares fell sharply, reversing from an earlier peak to drop to their lowest point late in the morning amid a broader decline.

17 sept. 2026, 22:41 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, moving lower alongside the broader market's significant downward movement.

16 sept. 2026, 20:13 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, significantly above its 20-day moving average since Wednesday's close.

15 sept. 2026, 20:13 UTC

West Pharmaceutical Services shares are lower in after-market hours amid negative market sentiment and concerns over economic momentum and potential interest rate hikes.

14 sept. 2026, 20:07 UTC

News

West Pharmaceutical Services is gaining as CFO discusses strong second-quarter results at the Morgan Stanley conference, despite a recent cyber incident.

11 sept. 2026, 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

10 sept. 2026, 20:51 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours amid challenging broader market conditions and declining existing home sales for August.

9 sept. 2026, 20:07 UTC

West Pharmaceutical Services Inc. trades roughly flat amid a broader market trend, remaining near the lower end of its one-month range.

8 sept. 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are higher in after-market trading, showing modest gains since Tuesday's close despite no specific news to explain the movement.

4 sept. 2026, 19:36 UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

3 sept. 2026, 22:01 UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2 sept. 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

1 sept. 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

31 août 2026, 20:07 UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

28 août 2026, 23:11 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

27 août 2026, 23:02 UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

26 août 2026, 19:26 UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

25 août 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

24 août 2026, 19:51 UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

21 août 2026, 23:01 UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

20 août 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

19 août 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

18 août 2026, 19:36 UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

17 août 2026, 22:55 UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

14 août 2026, 23:01 UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

13 août 2026, 23:36 UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

12 août 2026, 19:36 UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

Comparaison

Variation de prix

West Pharmaceutical Services Inc prévision

Objectif de Prix

By TipRanks

10.31% hausse

Prévisions sur 12 Mois

Moyen 412.111 USD  10.31%

Haut 447 USD

Bas 390 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

10 ratings

10

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

307 / 339Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.